Small Molecules for Precision Medicine

Learn More about Arqule

We are pursuing multiple programs in biomarker-defined oncology and rare disease indications

Targeted Approach to Cancer

Clinical Trials

Research & Development

Product Pipeline

Targeted Approach To

Rare Diseases

News & Events

September 29, 2017

Proteus Syndrome Phase 1 Data Presentation

ArQule to Present at the 20th Annual B. Riley FBR Institutional Investor Conference on May 22, 2019

ArQule to Present at the 2019 RBC Capital Markets Global Healthcare Conference on May 21, 2019

More News & Events »